tradingkey.logo

Metagenomi Inc

MGX
2.290USD
-0.130-5.37%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
85.95MValor de mercado
PerdaP/L TTM

Mais detalhes de Metagenomi Inc Empresa

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed an expansive and modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. Its platform enables it to rapidly and effectively find, screen, and select tools with the highest targetability, specificity, and efficiency in order to develop them into genetic medicine.

Informações de Metagenomi Inc

Código da empresaMGX
Nome da EmpresaMetagenomi Inc
Data de listagemFeb 09, 2024
CEODr. Brian C. Thomas, Ph.D.
Número de funcionários202
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 09
Endereço5959 Horton St
CidadeEMERYVILLE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94608
Telefone15108714880
Sitehttps://metagenomi.co/
Código da empresaMGX
Data de listagemFeb 09, 2024
CEODr. Brian C. Thomas, Ph.D.

Executivos da empresa Metagenomi Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Lead Independent Director
Lead Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
2.37M
-0.45%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
579.04K
-1.09%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.58%
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.31%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.35%
Bernales (Sebastian Ph.D.)
3.12%
Outro
71.37%
Investidores
Investidores
Proporção
Bayer HealthCare LLC
10.79%
Thomas (Brian C)
6.31%
Humboldt Capital, LLC
5.05%
The Vanguard Group, Inc.
3.35%
Bernales (Sebastian Ph.D.)
3.12%
Outro
71.37%
Tipos de investidores
Investidores
Proporção
Corporation
15.85%
Individual Investor
12.24%
Investment Advisor
8.44%
Hedge Fund
3.20%
Venture Capital
2.96%
Investment Advisor/Hedge Fund
2.37%
Research Firm
1.57%
Sovereign Wealth Fund
0.67%
Outro
52.70%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
156
7.21M
19.21%
-9.72M
2025Q2
159
20.26M
54.19%
-7.71M
2025Q1
157
20.44M
54.67%
-7.64M
2024Q4
143
21.51M
57.48%
-2.78M
2024Q3
116
23.74M
63.40%
-1.13M
2024Q2
94
26.05M
69.54%
+4.67M
2024Q1
65
26.68M
71.20%
+16.22M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Bayer HealthCare LLC
4.05M
10.79%
--
--
Sep 30, 2024
Thomas (Brian C)
2.37M
6.31%
-10.79K
-0.45%
Jun 06, 2025
Humboldt Capital, LLC
1.90M
5.05%
--
--
Apr 14, 2025
The Vanguard Group, Inc.
1.26M
3.35%
-199.55K
-13.69%
Jun 30, 2025
Bernales (Sebastian Ph.D.)
1.17M
3.12%
--
--
Apr 14, 2025
Sozo Ventures LLC
581.58K
1.55%
--
--
Jun 30, 2025
Irish (Jian)
579.04K
1.54%
-6.39K
-1.09%
Jun 06, 2025
Catalio Capital Management, LP
528.99K
1.41%
--
--
Jun 30, 2025
Peapod Lane Capital LLC
508.11K
1.35%
+155.65K
+44.16%
Jun 30, 2025
Millennium Management LLC
383.03K
1.02%
+197.93K
+106.92%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
Global X Russell 2000 ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
Proporção0.01%
iShares Russell 2000 Value ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Schwab U.S. Small-Cap ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI